These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 1973197)

  • 1. Serotonergic modulation of rat pup ultrasonic vocal development: studies with 3,4-methylenedioxymethamphetamine.
    Winslow JT; Insel TR
    J Pharmacol Exp Ther; 1990 Jul; 254(1):212-20. PubMed ID: 1973197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 3,4-Methylenedioxymethamphetamine and 3,4-methylenedioxyamphetamine destroy serotonin terminals in rat brain: quantification of neurodegeneration by measurement of [3H]paroxetine-labeled serotonin uptake sites.
    Battaglia G; Yeh SY; O'Hearn E; Molliver ME; Kuhar MJ; De Souza EB
    J Pharmacol Exp Ther; 1987 Sep; 242(3):911-6. PubMed ID: 2443644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Repeated adolescent 3,4-methylenedioxymethamphetamine (MDMA) exposure in rats attenuates the effects of a subsequent challenge with MDMA or a 5-hydroxytryptamine(1A) receptor agonist.
    Piper BJ; Vu HL; Safain MG; Oliver AJ; Meyer JS
    J Pharmacol Exp Ther; 2006 May; 317(2):838-49. PubMed ID: 16434566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of endogenous dopamine in the central serotonergic deficits induced by 3,4-methylenedioxymethamphetamine.
    Stone DM; Johnson M; Hanson GR; Gibb JW
    J Pharmacol Exp Ther; 1988 Oct; 247(1):79-87. PubMed ID: 2902215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 3,4-Methylenedioxymethamphetamine ("ecstasy") selectively destroys brain serotonin terminals in rhesus monkeys.
    Insel TR; Battaglia G; Johannessen JN; Marra S; De Souza EB
    J Pharmacol Exp Ther; 1989 Jun; 249(3):713-20. PubMed ID: 2471824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Caffeine promotes hyperthermia and serotonergic loss following co-administration of the substituted amphetamines, MDMA ("Ecstasy") and MDA ("Love").
    McNamara R; Kerans A; O'Neill B; Harkin A
    Neuropharmacology; 2006 Jan; 50(1):69-80. PubMed ID: 16188283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevation of serum prolactin and corticosterone concentrations in the rat after the administration of 3,4-methylenedioxymethamphetamine.
    Nash JF; Meltzer HY; Gudelsky GA
    J Pharmacol Exp Ther; 1988 Jun; 245(3):873-9. PubMed ID: 2898523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo analysis of serotonin clearance in rat hippocampus reveals that repeated administration of p-methoxyamphetamine (PMA), but not 3,4-methylenedioxymethamphetamine (MDMA), leads to long-lasting deficits in serotonin transporter function.
    Callaghan PD; Owens WA; Javors MA; Sanchez TA; Jones DJ; Irvine RJ; Daws LC
    J Neurochem; 2007 Feb; 100(3):617-27. PubMed ID: 17181558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lasting effects of (+-)-3,4-methylenedioxymethamphetamine (MDMA) on central serotonergic neurons in nonhuman primates: neurochemical observations.
    Ricaurte GA; Martello AL; Katz JL; Martello MB
    J Pharmacol Exp Ther; 1992 May; 261(2):616-22. PubMed ID: 1374470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serotonin release contributes to the locomotor stimulant effects of 3,4-methylenedioxymethamphetamine in rats.
    Callaway CW; Wing LL; Geyer MA
    J Pharmacol Exp Ther; 1990 Aug; 254(2):456-64. PubMed ID: 1974635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of a serotonin depleting regimen of 3,4-methylenedioxymethamphetamine (MDMA) on the subsequent stimulation of acetylcholine release in the rat prefrontal cortex.
    Nair SG; Gudelsky GA
    Brain Res Bull; 2006 Apr; 69(4):382-7. PubMed ID: 16624669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of 3,4-methylenedioxyamphetamine and 3,4-methylenedioxymethamphetamine isomers on central serotonergic, dopaminergic and nigral neurotensin systems of the rat.
    Johnson M; Letter AA; Merchant K; Hanson GR; Gibb JW
    J Pharmacol Exp Ther; 1988 Mar; 244(3):977-82. PubMed ID: 2472482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Behavioral and neurochemical effects of orally administered MDMA in the rodent and nonhuman primate.
    Slikker W; Holson RR; Ali SF; Kolta MG; Paule MG; Scallet AC; McMillan DE; Bailey JR; Hong JS; Scalzo FM
    Neurotoxicology; 1989; 10(3):529-42. PubMed ID: 2576304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of amphetamine-like designer drugs on monoaminergic systems in rat brain.
    Gibb JW; Stone DM; Stahl DC; Hanson GR
    NIDA Res Monogr; 1987; 76():316-21. PubMed ID: 2449619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biochemical and histological evidence that methylenedioxymethylamphetamine (MDMA) is toxic to neurons in the rat brain.
    Commins DL; Vosmer G; Virus RM; Woolverton WL; Schuster CR; Seiden LS
    J Pharmacol Exp Ther; 1987 Apr; 241(1):338-45. PubMed ID: 2883295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the behavioral and neurochemical effects of 5,7-DHT, MDMA and D,L-fenfluramine.
    Lorens SA; Hata N; Cabrera T; Hamilton ME
    NIDA Res Monogr; 1989; 95():347. PubMed ID: 2577039
    [No Abstract]   [Full Text] [Related]  

  • 17. Neurotoxicity of the psychedelic amphetamine, methylenedioxymethamphetamine.
    Schmidt CJ
    J Pharmacol Exp Ther; 1987 Jan; 240(1):1-7. PubMed ID: 2433425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 3,4-Methylenedioxymethamphetamine- and 8-hydroxy-2-di-n-propylamino-tetralin-induced hypothermia: role and location of 5-hydroxytryptamine 1A receptors.
    Rusyniak DE; Zaretskaia MV; Zaretsky DV; DiMicco JA
    J Pharmacol Exp Ther; 2007 Nov; 323(2):477-87. PubMed ID: 17702902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diminished corticotropin and enhanced prolactin responses to 8-hydroxy-2(di-n-propylamino)tetralin in methylenedioxymethamphetamine pretreated rats.
    Poland RE
    Neuropharmacology; 1990 Nov; 29(11):1099-101. PubMed ID: 1982341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serotonin depletion unmasks serotonergic component of [3H]dihydroalprenolol binding in rat brain.
    Stockmeier CA; Kellar KJ
    Mol Pharmacol; 1989 Dec; 36(6):903-11. PubMed ID: 2557537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.